Stay updated on ARGX-110 with Azacytidine in AML Clinical Trial
Sign up to get notified when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.

Latest updates to the ARGX-110 with Azacytidine in AML Clinical Trial page
- Check2 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', signaling that enrollment is closed. The page adds help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision label to v3.6.0, while the 'Intervention / Treatment' label was standardized to 'Intervention/Treatment' and the prior revision tag v3.5.5 was removed.SummaryDifference0.4%

- Check9 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a minor update to the study record metadata.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a maintenance update to the study record display.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision tag v3.5.3 was added to the study record history, indicating a minor update to the page. The previous v3.5.2 tag was removed as part of this update.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page revision tag was updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.1%

- Check88 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page.SummaryDifference0.1%

Stay in the know with updates to ARGX-110 with Azacytidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.